Markers in the epidermal growth factor receptor pathway and skin toxicity during erlotinib treatment

Overview of attention for article published in Annals of Oncology, September 2007

Altmetric Badge

Mentioned by

patent: 3 patents

Readers on

mendeley: 30 Mendeley
connotea: 1 Connotea

So far, Altmetric has seen 3 patents that reference this research output.

Selective inhibitors of Tec and Src protein kinase families

Grant US-9796716-B2

United States of America

Compositions for Preventing or Treating Adverse Reactions of EGFR Inhibition

Application US-20140322308-A1

United States of America

Combination Therapy with an Antitumor Alkaloid

Application US-20110070232-A1

United States of America

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity.